Quarterly Transactions Made in Syros Pharmaceuticals, Inc. (SYRS)
This table provides information about the institutional ownership of Syros Pharmaceuticals, Inc. (SYRS). The information is specifically focused on institutions that hold shares of Syros Pharmaceuticals, Inc..
Shares Purchased
Shares Sold
| Quarter | Buy | Sell | Net Activity | |||||
|---|---|---|---|---|---|---|---|---|
| New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
| Q3 2019 | 5,154,634 | 4,032,653 | 9,187,287 | 352,036 | 397,567 | 749,603 | 8,437,684 | |
| Q4 2019 | 2,643,633 | 1,207,538 | 3,851,171 | 4,732,219 | 710,915 | 5,443,134 | -1,591,963 | |
| Q1 2020 | 1,163,262 | 3,652,499 | 4,815,761 | 540,685 | 899,735 | 1,440,420 | 3,375,341 | |
| Q2 2020 | 3,635,321 | 935,336 | 4,570,657 | 4,240,241 | 1,389,367 | 5,629,608 | -1,058,951 | |
| Q3 2020 | 3,769,987 | 508,105 | 4,278,092 | 2,849,162 | 195,517 | 3,044,679 | 1,233,413 | |
| Q4 2020 | 2,018,995 | 13,674,381 | 15,693,376 | 3,396,637 | 1,105,063 | 4,501,700 | 11,191,676 | |
| Q1 2021 | 4,078,634 | 1,467,211 | 5,545,845 | 2,360,804 | 798,021 | 3,158,825 | 2,387,020 | |
| Q2 2021 | 4,296,771 | 19,617,634 | 23,914,405 | 1,773,296 | 18,415,108 | 20,188,404 | 3,726,001 | |
| Q3 2021 | 2,438,662 | 1,181,536 | 3,620,198 | 1,461,027 | 1,717,009 | 3,178,036 | 442,162 | |
| Q4 2021 | 2,728,740 | 495,533 | 3,224,273 | 1,334,110 | 1,037,955 | 2,372,065 | 852,208 | |
| Q1 2022 | 1,588,788 | 1,337,963 | 2,926,751 | 5,417,399 | 4,090,348 | 9,507,747 | -6,580,996 | |
| Q2 2022 | 2,113,946 | 1,400,891 | 3,514,837 | 8,403,752 | 3,873,308 | 12,277,060 | -8,762,223 | |
| Q3 2022 | 0 | 219 | 219 | 1,018,166 | 4,411,510 | 5,429,676 | -5,429,457 | |